Showing results (1831-1840 of 2,669) with videos related to
Sort By:
Pageof 267
Oncology Research|January 30, 2026
PIK3R1 as a Gastric Cancer Biomarker Linked to CD73 + Treg-Mediated ImmunosuppressionBu Zou, Yi-En Xu, Hui-Chan He, et al.Oncology Research|January 8, 2026
Application Value and Research Frontiers of Immunotherapy in Glioblastoma: A Bibliometric and Visualized AnalysisKun Deng, Jianliang Huang, Danyang Li, et al.Oncology Research|January 8, 2026
Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug ResistanceRabindranath Bera, Yotaro Ochi, Ying-Jung Huang, et al.Oncology Research|January 8, 2026
PNP as a Metabolic and Prognostic Driver of Breast Cancer Aggressiveness: Insights from Patient Tissue and Cell ModelsSarra B Shakartalla, Iman M Talaat, Nival Ali, et al.Oncology Research|January 8, 2026
Pan-Cancer Analysis of Enhancer-Induced PAN3-AS1 and Experimental Validation as a WFDC13-Promoting Factor in Colon CancerXu Guo, Yanan Yu, Xiaolin Ma, et al.Oncology Research|January 8, 2026
HE4 Might Participate in Extracellular Matrix Remodeling in Ovarian Cancer via Activation of FibroblastsYimin Liu, Bin Liu, Huabin Gao, et al.Oncology Research|December 30, 2024
Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapyEnrico Caliman, Sara Fancelli, Federico Scolari, et al.Oncology Research|December 30, 2024
HNRNPC as a pan-cancer biomarker and therapeutic target involved in tumor progression and immune regulationYuezhou Zhang, Zhao Zhang, Jinxin Dong, et al.Oncology Research|December 30, 2024
SBL-JP-0004: A promising dual inhibitor of JAK2 and PI3KCD against gastric cancerHassan M OtifiOncology Research|January 8, 2024
New perspectives on biology, disease progression, and therapy response of head and neck cancer gained from single cell RNA sequencing and spatial transcriptomicsGerwin Heller, Thorsten Fuereder, Alexander Michael Grandits, et al.Pageof 267